drugset / Trial / NCT00000553

HDL-Atherosclerosis Treatment Study (HATS)

NCT00000553

RandomizedFactorialPrevention

Summary

To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high density lipoprotein (HDL) cholesterol.

Timeline

Start
1994-09
Primary completion
Completion
2001-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule
Subject Simvastatin Small molecule